Correction: Oral Antiviral Treatments for Covid-19: Opportunities and Challenges (Pharmacological Reports, (2022), 74, 6, (1255-1278), 10.1007/S43440-022-00388-7)

Correction: Oral Antiviral Treatments for Covid-19: Opportunities and Challenges (Pharmacological Reports, (2022), 74, 6, (1255-1278), 10.1007/S43440-022-00388-7) Publisher

Rahmah L^{1, 2} ; Abarikwu SO^{3, 4} ; Arero AG^{5, 6} ; Essouma M^{25, 26} ; Jibril AT^{7, 8, 9} ; Fal A^{10, 11, 12} ; Flisiak R¹³ ; Makuku R^{1, 14} ; Marquez L^{15, 16} ; Mohamed K^{1, 17} ; Ndow L^{18, 19} ; Zarebskamichaluk D²⁰ ; Rezaei N^{21, 22, 23} ; Rzymski P^{12, 24}

Source: Pharmacological Reports Published:2022

Abstract

The original version of this article unfortunately did not list Mickael Essouma as a co-author who has been involved in the drafting and approving of the manuscript. A correct list of authors is as follows: Laila Rahmah, Sunny O. Abarikwu, Amanuel Godana Arero, Mickael Essouma, Aliyu Tijani Jibril, Andrzej Fal, Robert Flisiak, Rangarirai Makuku, Leander Marquez, Kawthar Mohamed, Lamin Ndow, Dorota Zarebska-Michaluk, Nima Rezaei & Piotr Rzymski. © The Author(s) 2022.

Related Docs

1. Corrigendum: Thrombotic Microangiopathy in the Renal Allograft: Results of the Tma Banff Working Group Consensus on Pathologic Diagnostic Criteria, Transplant international : official journal of the European Society for Organ Transplantation (2023)

2. Correction: Oncolytic Paramyxoviruses-Induced Autophagy; a Prudent Weapon for Cancer Therapy (Journal of Biomedical Science (2019) 26 (48) Doi: 10.1186/S12929-019-0542-9), Journal of Biomedical Science (2019)

3. Corrigendum: Delphi: A Democratic and Cost-Effective Method of Consensus Generation in Transplantation, Transplant international : official journal of the European Society for Organ Transplantation (2023)

Style	Citing Format
MLA	Rahmah L, et al.. "Correction: Oral Antiviral Treatments for Covid-19: Opportunities and Challenges (Pharmacological Reports, (2022), 74, 6, (1255-1278), 10.1007/S43440-022-00388-7)." Pharmacological Reports, vol. 74, no. 6, 2022, pp. 1326-1327.
APA	Rahmah L, Abarikwu SO, Arero AG, Essouma M, Jibril AT, Fal A, Flisiak R, Makuku R, Marquez L, Mohamed K, Ndow L, Zarebskamichaluk D, Rezaei N, Rzymski P (2022). Correction: Oral Antiviral Treatments for Covid-19: Opportunities and Challenges (Pharmacological Reports, (2022), 74, 6, (1255-1278), 10.1007/S43440-022-00388-7). Pharmacological Reports, 74(6), 1326-1327.
Chicago	Rahmah L, Abarikwu SO, Arero AG, Essouma M, Jibril AT, Fal A, Flisiak R, et al.. "Correction: Oral Antiviral Treatments for Covid-19: Opportunities and Challenges (Pharmacological Reports, (2022), 74, 6, (1255-1278), 10.1007/S43440-022-00388-7)." Pharmacological Reports 74, no. 6 (2022): 1326-1327.
Harvard	Rahmah L et al. (2022) 'Correction: Oral Antiviral Treatments for Covid-19: Opportunities and Challenges (Pharmacological Reports, (2022), 74, 6, (1255-1278), 10.1007/S43440-022-00388-7)', Pharmacological Reports, 74(6), pp. 1326-1327.
Vancouver	Rahmah L, Abarikwu SO, Arero AG, Essouma M, Jibril AT, Fal A, et al.. Correction: Oral Antiviral Treatments for Covid-19: Opportunities and Challenges (Pharmacological Reports, (2022), 74, 6, (1255-1278), 10.1007/S43440-022-00388-7). Pharmacological Reports. 2022;74(6):1326-1327.
BibTex	@article{ author = {Rahmah L and Abarikwu SO and Arero AG and Essouma M and Jibril AT and Fal A and Flisiak R and Makuku R and Marquez L and Mohamed K and Ndow L and Zarebskamichaluk D and Rezaei N and Rzymski P}, title = {Correction: Oral Antiviral Treatments for Covid-19: Opportunities and Challenges (Pharmacological Reports, (2022), 74, 6, (1255-1278), 10.1007/S43440-022-00388-7)}, journal = {Pharmacological Reports}, volume = {74}, number = {6}, pages = {1326-1327}, year = {2022} }
RIS	TY - JOUR AU - Rahmah L AU - Abarikwu SO AU - Arero AG AU - Essouma M AU - Jibril AT AU - Fal A AU - Flisiak R AU - Makuku R AU - Marquez L AU - Mohamed K AU - Ndow L AU - Zarebskamichaluk D AU - Rezaei N AU - Rzymski P TI - Correction: Oral Antiviral Treatments for Covid-19: Opportunities and Challenges (Pharmacological Reports, (2022), 74, 6, (1255-1278), 10.1007/S43440-022-00388-7) JO - Pharmacological Reports VL - 74 IS - 6 SP - 1326 EP - 1327 PY - 2022 ER -

Style

Citing Format

MLA

Rahmah L, et al.. "Correction: Oral Antiviral Treatments for Covid-19: Opportunities and Challenges (Pharmacological Reports, (2022), 74, 6, (1255-1278), 10.1007/S43440-022-00388-7)." Pharmacological Reports, vol. 74, no. 6, 2022, pp. 1326-1327.

APA

Rahmah L, Abarikwu SO, Arero AG, Essouma M, Jibril AT, Fal A, Flisiak R, Makuku R, Marquez L, Mohamed K, Ndow L, Zarebskamichaluk D, Rezaei N, Rzymski P (2022). Correction: Oral Antiviral Treatments for Covid-19: Opportunities and Challenges (Pharmacological Reports, (2022), 74, 6, (1255-1278), 10.1007/S43440-022-00388-7). Pharmacological Reports, 74(6), 1326-1327.

Chicago

Rahmah L, Abarikwu SO, Arero AG, Essouma M, Jibril AT, Fal A, Flisiak R, et al.. "Correction: Oral Antiviral Treatments for Covid-19: Opportunities and Challenges (Pharmacological Reports, (2022), 74, 6, (1255-1278), 10.1007/S43440-022-00388-7)." Pharmacological Reports 74, no. 6 (2022): 1326-1327.

Harvard

Rahmah L et al. (2022) 'Correction: Oral Antiviral Treatments for Covid-19: Opportunities and Challenges (Pharmacological Reports, (2022), 74, 6, (1255-1278), 10.1007/S43440-022-00388-7)', Pharmacological Reports, 74(6), pp. 1326-1327.

Vancouver

Rahmah L, Abarikwu SO, Arero AG, Essouma M, Jibril AT, Fal A, et al.. Correction: Oral Antiviral Treatments for Covid-19: Opportunities and Challenges (Pharmacological Reports, (2022), 74, 6, (1255-1278), 10.1007/S43440-022-00388-7). Pharmacological Reports. 2022;74(6):1326-1327.

BibTex

@article{ author = {Rahmah L and Abarikwu SO and Arero AG and Essouma M and Jibril AT and Fal A and Flisiak R and Makuku R and Marquez L and Mohamed K and Ndow L and Zarebskamichaluk D and Rezaei N and Rzymski P}, title = {Correction: Oral Antiviral Treatments for Covid-19: Opportunities and Challenges (Pharmacological Reports, (2022), 74, 6, (1255-1278), 10.1007/S43440-022-00388-7)}, journal = {Pharmacological Reports}, volume = {74}, number = {6}, pages = {1326-1327}, year = {2022} }

RIS

TY - JOUR
AU - Rahmah L
AU - Abarikwu SO
AU - Arero AG
AU - Essouma M
AU - Jibril AT
AU - Fal A
AU - Flisiak R
AU - Makuku R
AU - Marquez L
AU - Mohamed K
AU - Ndow L
AU - Zarebskamichaluk D
AU - Rezaei N
AU - Rzymski P
TI - Correction: Oral Antiviral Treatments for Covid-19: Opportunities and Challenges (Pharmacological Reports, (2022), 74, 6, (1255-1278), 10.1007/S43440-022-00388-7)
JO - Pharmacological Reports
VL - 74
IS - 6
SP - 1326
EP - 1327
PY - 2022
ER -

Science Communicator Platform

Authors

Abstract